What's in Alfred E. Tiefenbacher (GmbH & Co. KG)'s pipeline?

Alfred E. Tiefenbacher (GmbH & Co. KG) has 1 drugs in our index: 0 marketed, 0 filed, 1 in Phase 3, 0 in Phase 2, 0 in Phase 1.

Which companies overlap with Alfred E. Tiefenbacher (GmbH & Co. KG)'s portfolio?

Top competitors by shared drug class: Actavis Inc., Bausch & Lomb Incorporated, Beijing Tiantan Hospital, Merck Sharp & Dohme LLC, National University Hospital, Singapore.

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/alfred-e-tiefenbacher-gmbh-co-kg.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-05-17 · How we verify

Alfred E. Tiefenbacher (GmbH & Co. KG) — Portfolio Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Alfred E. Tiefenbacher (GmbH & Co. KG) pipeline: 0 marketed, 0 filed, 1 Phase 3, 0 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

0 marketed 0 filed 1 Phase 3 0 Phase 2 0 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Target	Area	First approval
Dorzolamide 2 % eye drops solution	Dorzolamide 2 % eye drops solution	phase 3	Carbonic anhydrase inhibitor	Carbonic anhydrase II	Ophthalmology

Therapeutic area mix

Ophthalmology · 1

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

Actavis Inc. · 1 shared drug class
Bausch & Lomb Incorporated · 1 shared drug class
Beijing Tiantan Hospital · 1 shared drug class
Merck Sharp & Dohme LLC · 1 shared drug class
National University Hospital, Singapore · 1 shared drug class
Padagis LLC · 1 shared drug class
Rabin Medical Center · 1 shared drug class
Shahid Beheshti University of Medical Sciences · 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for Alfred E. Tiefenbacher (GmbH & Co. KG):

Cite this brief

Drug Landscape (2026). Alfred E. Tiefenbacher (GmbH & Co. KG) — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/alfred-e-tiefenbacher-gmbh-co-kg. Accessed 2026-05-17.